Singapore markets close in 5 hours 17 minutes

Monterey Capital Acquisition Corporation (MCAC)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
11.23+0.00 (+0.04%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 108.66M
Enterprise value 109.84M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.18
Enterprise value/revenue N/A
Enterprise value/EBITDA -36.85

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 39.03%
S&P500 52-week change 321.08%
52-week high 311.33
52-week low 310.30
50-day moving average 311.07
200-day moving average 310.81

Share statistics

Avg vol (3-month) 321.32k
Avg vol (10-day) 368.43k
Shares outstanding 57.38M
Implied shares outstanding 69.68M
Float 84.73M
% held by insiders 11.02%
% held by institutions 1103.27%
Shares short (15 Apr 2024) 41.27k
Short ratio (15 Apr 2024) 40.03
Short % of float (15 Apr 2024) 40.02%
Short % of shares outstanding (15 Apr 2024) 40.01%
Shares short (prior month 15 Mar 2024) 41.27k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-2.15%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-14.94M
Diluted EPS (ttm)-1.32
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.95k
Total cash per share (mrq)0
Total debt (mrq)1.18M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.01
Book value per share (mrq)-2.99

Cash flow statement

Operating cash flow (ttm)-2.45M
Levered free cash flow (ttm)1.91M